KalVista Pharmaceuticals, Inc. Gains 114.61%
Tue, Feb 09, 2021 at 05:32 PM
KalVista Pharmaceuticals, Inc. (KALV:NASDAQ) shot up at $33.5, a gain of 114.6%. The stock appeared on our News Catalysts scanner on Tue 09 Feb 21 at 05:06 PM in the 'EARNINGS' category. From Mon 25 Jan 21, the stock recorded 30.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About KalVista Pharmaceuticals, Inc. (KALV:NASDAQ)
KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.
Top 10 Gainers:
- AUVI (AUVI:NASDAQ), 280.5%
- KalVista Pharmaceuticals, Inc. (KALV:NASDAQ), 114.61%
- Comstock Holding Companies, Inc. (CHCI:NASDAQ), 98.58%
- Globalstar, Inc. (GSAT:NYSEMKT), 69.11%
- Salem Media Group, Inc. (SALM:NASDAQ), 55.49%
- Eastside Distilling, Inc. (EAST:NASDAQ), 54.24%
- PDS Biotechnology Corporation (PDSB:NASDAQ), 53.38%
- Neovasc Inc. (NVCN:NASDAQ), 52.67%
- Heat Biologics, Inc. (HTBX:NASDAQ), 49.82%
- BSQUARE Corporation (BSQR:NASDAQ), 47.63%